Cargando...
BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients
BACKGROUND: Anaplastic thyroid carcinoma (ATC) is the most aggressive cancer in humans with no optimal treatment strategy available. The molecular mechanisms of ATC remain unclear. The aim of this study was to investigate the prognostic value and role of BRMS1 in the progression of ATC. METHODS: BRM...
Guardado en:
| Publicado en: | Onco Targets Ther |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6718127/ https://ncbi.nlm.nih.gov/pubmed/31695409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S219506 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|